| Bhatt Elizabeth | President and COO | 0.37% | 174,209 | Feb 18, 2026 |
| Shaikhly Samira | Chief People Officer | <0.01% | 793 | Mar 2, 2026 |
| Finer Jeffrey | Chief Executive Officer · Director | — | — | Feb 6, 2026 |
| Kim Jae B. | Chief Medical Officer | — | — | Feb 6, 2026 |
| Klein Uwe | SVP, Biological Sciences | — | — | Feb 6, 2026 |
| Kolchinsky Peter | Director · 10% owner | — | — | — |
| Labrucherie Gil M | Chief Financial Officer | — | — | Feb 6, 2026 |
| Long Daniel D. | SVP, Drug Discovery | — | — | Feb 6, 2026 |
| RA Capital Healthcare Fund LP | Director · 10% owner | — | — | — |
| RA Capital Management, L.P. | Director · 10% owner | — | — | Jun 26, 2026 |
| RA Capital Nexus Fund III, L.P. | Director | — | — | — |
| Shah Rajeev M. | Director · 10% owner | — | — | — |
| Sharp Shalini | Director | — | — | Jun 26, 2026 |
| Wilson Mark Andrew | Chief Legal Officer | — | — | Feb 6, 2026 |